Interdisciplinary Melanoma Cooperative Group
Iman Osman has not added Biography.
If you are Iman Osman and would like to personalize this page please email our Author Liaison for assistance.
Melanoma expression of matrix metalloproteinase-23 is associated with blunted tumor immunity and poor responses to immunotherapy.
Journal of translational medicine Dec, 2014 | Pubmed ID: 25491880
RSK1 activation promotes invasion in nodular melanoma.
The American journal of pathology Mar, 2015 | Pubmed ID: 25579842
Genetic associations of the interleukin locus at 1q32.1 with clinical outcomes of cutaneous melanoma.
Journal of medical genetics Apr, 2015 | Pubmed ID: 25604082
Phosphorylation of eIF2α triggered by mTORC1 inhibition and PP6C activation is required for autophagy and is aberrant in PP6C-mutated melanoma.
Science signaling Mar, 2015 | Pubmed ID: 25759478
Sensitivity of plasma BRAFmutant and NRASmutant cell-free DNA assays to detect metastatic melanoma in patients with low RECIST scores and non-RECIST disease progression.
Molecular oncology Jan, 2016 | Pubmed ID: 26440707
Identification of a Novel Pathogenic Germline KDR Variant in Melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 05, 2016 | Pubmed ID: 26631613
The Expression Quantitative Trait Loci in Immune Pathways and their Effect on Cutaneous Melanoma Prognosis.
Clinical cancer research : an official journal of the American Association for Cancer Research 07, 2016 | Pubmed ID: 26733611
Pathways for Modulating Exosome Lipids Identified By High-Density Lipoprotein-Like Nanoparticle Binding to Scavenger Receptor Type B-1.
Scientific reports Mar, 2016 | Pubmed ID: 26964503
De Novo vs Nevus-Associated Melanomas: Differences in Associations With Prognostic Indicators and Survival.
Journal of the National Cancer Institute 10, 2016 | Pubmed ID: 27235387
Constitutive Lck Activity Drives Sensitivity Differences between CD8+ Memory T Cell Subsets.
Journal of immunology (Baltimore, Md. : 1950) 07, 2016 | Pubmed ID: 27271569
Genetic markers of pigmentation are novel risk loci for uveal melanoma.
Scientific reports Aug, 2016 | Pubmed ID: 27499155
Outcomes in Melanoma Patients Treated with BRAF/MEK-Directed Therapy or Immune Checkpoint Inhibition Stratified by Clinical Trial versus Standard of Care.
Oncology , 2017 | Pubmed ID: 28601879
A Systems Biology Approach Identifies FUT8 as a Driver of Melanoma Metastasis.
Cancer cell 06, 2017 | Pubmed ID: 28609658
Pre-metastatic cancer exosomes induce immune surveillance by patrolling monocytes at the metastatic niche.
Nature communications 11, 2017 | Pubmed ID: 29105655
Baseline antibody profiles predict toxicity in melanoma patients treated with immune checkpoint inhibitors.
Journal of translational medicine 04, 2018 | Pubmed ID: 29606147
Adjuvant NY-ESO-1 vaccine immunotherapy in high-risk resected melanoma: a retrospective cohort analysis.
Journal for immunotherapy of cancer 05, 2018 | Pubmed ID: 29773080
Association between Ki-67 expression and clinical outcomes among patients with clinically node-negative, thick primary melanoma who underwent nodal staging.
Journal of surgical oncology Jul, 2018 | Pubmed ID: 29878361
Development of Novel Mutation-Specific Droplet Digital PCR Assays Detecting TERT Promoter Mutations in Tumor and Plasma Samples.
The Journal of molecular diagnostics : JMD 03, 2019 | Pubmed ID: 30827467
Autoimmune genetic risk variants as germline biomarkers of response to melanoma immune-checkpoint inhibition.
Cancer immunology, immunotherapy : CII Jun, 2019 | Pubmed ID: 30863922
Impact of initial stage on metastatic melanoma survival.
Melanoma research 06, 2019 | Pubmed ID: 31026246
Immunomodulatory germline variation associated with the development of multiple primary melanoma (MPM).
Scientific reports 07, 2019 | Pubmed ID: 31308438
The complex relationship between body mass index and response to immune checkpoint inhibition in metastatic melanoma patients.
Journal for immunotherapy of cancer 08, 2019 | Pubmed ID: 31426863
Relating the gut metagenome and metatranscriptome to immunotherapy responses in melanoma patients.
Genome medicine 10, 2019 | Pubmed ID: 31597568
Functional analysis of RPS27 mutations and expression in melanoma.
Pigment cell & melanoma research 05, 2020 | Pubmed ID: 31663663
Melanoma Prognosis: Accuracy of the American Joint Committee on Cancer Staging Manual Eighth Edition.
Journal of the National Cancer Institute 09, 2020 | Pubmed ID: 31977051
TERT, BRAF, and NRAS Mutational Heterogeneity between Paired Primary and Metastatic Melanoma Tumors.
The Journal of investigative dermatology 08, 2020 | Pubmed ID: 32087194
The urgency of utilizing COVID-19 biospecimens for research in the heart of the global pandemic.
Journal of translational medicine 06, 2020 | Pubmed ID: 32487093
Preliminary analysis of distinct clinical and biologic features of bone metastases in melanoma.
Melanoma research 10, 2020 | Pubmed ID: 32804707
Revisiting the association between skin toxicity and better response in advanced cancer patients treated with immune checkpoint inhibitors.
Journal of translational medicine 11, 2020 | Pubmed ID: 33176813
Using Machine Learning Algorithms to Predict Immunotherapy Response in Patients with Advanced Melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 01, 2021 | Pubmed ID: 33208341
Baseline prognostic nutritional index and changes in pretreatment body mass index associate with immunotherapy response in patients with advanced cancer.
Journal for immunotherapy of cancer 11, 2020 | Pubmed ID: 33219093
Treatment with therapeutic anticoagulation is not associated with immunotherapy response in advanced cancer patients.
Journal of translational medicine 01, 2021 | Pubmed ID: 33516263
Tumor immunogenomic signatures improve a prognostic model of melanoma survival.
Journal of translational medicine 02, 2021 | Pubmed ID: 33596955
Chronic Immune-Related Adverse Events Following Adjuvant Anti-PD-1 Therapy for High-risk Resected Melanoma.
JAMA oncology 05, 2021 | Pubmed ID: 33764387
The "Great Debate" at Melanoma Bridge 2020: December, 5th, 2020.
Journal of translational medicine 04, 2021 | Pubmed ID: 33827575
Correction to: The urgency of utilizing COVID-19 biospecimens for research in the heart of the global pandemic.
Journal of translational medicine Jun, 2021 | Pubmed ID: 34082754
Targeting the Atf7ip-Setdb1 Complex Augments Antitumor Immunity by Boosting Tumor Immunogenicity.
Cancer immunology research 11, 2021 | Pubmed ID: 34462284
Bacteroides vulgatus and Bacteroides dorei predict immune-related adverse events in immune checkpoint blockade treatment of metastatic melanoma.
Genome medicine 10, 2021 | Pubmed ID: 34641962
Deep Learning and Pathomics Analyses Reveal Cell Nuclei as Important Features for Mutation Prediction of BRAF-Mutated Melanomas.
The Journal of investigative dermatology Oct, 2021 | Pubmed ID: 34757067
The histone demethylase PHF8 regulates TGFβ signaling and promotes melanoma metastasis.
Science advances Feb, 2022 | Pubmed ID: 35179962
Arman Alberto Sorin Shadaloey1,2,
Alcida Karz1,2,
Rana S. Moubarak1,2,
Praveen Agrawal1,2,
Grace Levinson1,2,
Kevin Kleffman1,2,
Orlando Aristizabal3,4,
Iman Osman2,5,
Youssef Z. Wadghiri3,4,
Eva Hernando1,2
1Department of Pathology, NYU Grossman School of Medicine,
2Interdisciplinary Melanoma Cooperative Group, Perlmutter Cancer Center,
3Department of Radiology, NYU Grossman School of Medicine,
4Preclinical Imaging Core, NYU Grossman School of Medicine,
5Ronald Perelman Department of Dermatology, NYU Grossman School of Medicine
SOBRE A JoVE
Copyright © 2024 MyJoVE Corporation. Todos os direitos reservados